Is ANAB stock safe? | Glauxie AI

Q: Is ANAB stock safe?

AnaptysBio, Inc. (ANAB) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Daniel R. Faga. AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an... Employees: 104.

Q: What are the risks of investing in ANAB?

Identify key risks of investing in ANAB — debt, competition, volatility, and sector headwinds.

Q: Is ANAB a good long-term investment?

Evaluate ANAB as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does ANAB have?

Review ANAB total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is ANAB stock safe?

🦉

AnaptysBio, Inc. (ANAB)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEODaniel R. Faga

AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various...

Key Executives

Name	Title
Benjamin Stone	Chief Business Officer
Beth Mueller	Senior Vice President of Human Resources
Cailin Sibley FACR	Senior Vice President of Translational Medicine
Christopher Murphy	Chief Financial Officer
Daniel R. Faga	President, Chief Executive Officer & Director
David McKeon	Senior Vice President & Controller

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

ANAB Profile Financials

What are the risks of investing in ANAB? Is ANAB a good long-term investment? How much debt does ANAB have?